Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases
Condition(s):Hematologic MalignancyLast Updated:June 29, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Hematologic MalignancyLast Updated:June 29, 2012Completed
Condition(s):Hematological Malignancy; Leukemia; Lymphoma; Multiple MyelomaLast Updated:January 22, 2020Completed
Condition(s):Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia; ph+ Acute Lymphoblastic LeukemiaLast Updated:August 25, 2023Recruiting
Condition(s):LeukemiaLast Updated:June 10, 2015Terminated
Condition(s):Blood And Marrow Transplantation; Leukemia; Lymphoma; Transplantation Infection; Transplantation, Bone MarrowLast Updated:April 28, 2017Completed
Condition(s):Hematological MalignanciesLast Updated:January 26, 2023Completed
Condition(s):Hematologic MalignanciesLast Updated:April 4, 2012Completed
Condition(s):Acute Myeloid Leukemia; Acute Lymphoid Leukemia; Hematopoetic Myelodysplasia; Leukemia, Myelogenous, Chronic; Lymphoma, Non-HodgkinLast Updated:January 8, 2019Completed
Condition(s):Chronic Myelogous Leukemia/Other Leukemia; Acute Leukemias; MDS/MPS; Multiple Myeloma; Non-Hodgkin LymphomaLast Updated:December 21, 2018Withdrawn
Condition(s):LeukemiaLast Updated:June 17, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.